NCR1 and myalgic encephalomeyelitis/chronic fatigue syndrome: The expression of SLAM and NKp46 on NK cells significantly differed between moderate and severe CFS/ME patients, suggesting that perhaps these severity subgroups may vary in immunological presentation, as proposed by previous studies [5, 7, 13].